Multiple Assemblies exist for SMTL entry 5w5o
Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases.; X-RAY DIFFRACTION 2.89 Å

	SMTL ID 5w5o.1 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer
	SMTL ID 5w5o.2 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer
	SMTL ID 5w5o.3 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer
	SMTL ID 5w5o.4 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer
	SMTL ID 5w5o.5 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer
	SMTL ID 5w5o.6 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer
	SMTL ID 5w5o.7 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer
	SMTL ID 5w5o.8 Ligands 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine Polypeptides Receptor-interacting serine/threonine-protein kinase 2 Oligo-state homo-dimer